School of Population and Public Health, University of British Columbia, 2613 Melfa Lane, Vancouver, BC, Canada.
Clinical Prevention Services, British Columbia Centre for Disease Control, Vancouver, BC, Canada.
BMC Infect Dis. 2022 Aug 20;22(1):701. doi: 10.1186/s12879-022-07685-9.
BACKGROUND: Sexually Transmitted Infections (STIs) are of great global health concern. Currently, there are limited epidemiological data characterizing STIs in the general population in Rwanda. We assessed the national and regional epidemiology of STIs in Rwanda from 2014-2020 among patients syndromically screened for STIs in all health facilities in Rwanda. METHODS: This is a retrospective analysis of the trend of STIs epidemiology among screened patients at all health facilities in Rwanda using data from the Health Management Information System (HMIS) reporting. Adult patients (15 years and over) screened for STIs between July 2014 and June 2020 were included in the analysis. Outcomes of interest were the number of individuals screened for STIs and individuals diagnosed with at least one STI with a syndromic approach only or plus a test together. RESULTS: Overall, the number of individuals screened for STIs over the study period was 5.3 million (M) in 2014-2015, 6.6 M in 2015-2016, 6.3 M in 2016-2017, 6.7 M in 2017-2018, 6.2 M in 2018-2019, and 4.9 M in 2019-2020. There was a modest increase in the number of individuals diagnosed and treated for STIs from 139,357 in 2014-15 to 202,294 (45% increase) in 2019-2020. At the national level, the prevalence of STI syndromes amongst individuals screened at health facilities in Rwanda varied between 2.37% to 4.16% during the study period. Among the provinces, Kigali city had the highest prevalence for the whole 6 years ranging from 3.46% (95%CI: 3.41, 3.51) in 2014-2015 to 8.23% (95%CI: 8.15, 8.31) in 2019-2020. CONCLUSION: From 2014 to 2020, the number of patients screened for STI syndromes in Rwanda varied between 4.9 M and 6.7 M. However, the prevalence of STIs among screened patients increased considerably over time, which could be associated with public awareness and improved data recording. The highest prevalence of all STIs was observed in urban areas and near borders, and private clinics reported more cases, suggesting the need to improve awareness in these settings and increase confidentiality and trust in public health clinics.
背景：性传播感染（STIs）是全球健康的重要关注点。目前，卢旺达一般人群中 STIs 的流行病学数据有限。我们评估了 2014 年至 2020 年期间卢旺达所有卫生设施中对性传播感染进行综合征筛查的患者中 STIs 的国家和区域流行病学情况。
方法：这是对卢旺达所有卫生设施中通过性传播感染综合征筛查的患者的 STIs 流行病学趋势进行的回顾性分析，使用来自卫生管理信息系统（HMIS）报告的数据。本分析纳入了 2014 年 7 月至 2020 年 6 月期间接受性传播感染筛查的年龄在 15 岁及以上的成年患者。主要结局是接受性传播感染综合征筛查的个体数量以及仅通过综合征方法或加用检测方法诊断出至少有一种性传播感染的个体数量。
结果：总体而言，2014-2015 年期间接受性传播感染筛查的个体数量为 530 万（M），2015-2016 年为 660 万，2016-2017 年为 630 万，2017-2018 年为 670 万，2018-2019 年为 620 万，2019-2020 年为 490 万。接受性传播感染诊断和治疗的个体数量从 2014-15 年的 139357 例增加到 2019-2020 年的 202294 例（增加了 45%）。在国家层面，卢旺达卫生设施接受性传播感染综合征筛查的个体中，性传播感染综合征的患病率在研究期间介于 2.37%至 4.16%之间。在各省中，基加利市在整个 6 年期间的患病率最高，从 2014-2015 年的 3.46%（95%CI：3.41，3.51）到 2019-2020 年的 8.23%（95%CI：8.15，8.31）。
结论：2014 年至 2020 年期间，卢旺达接受性传播感染综合征筛查的患者数量在 490 万至 670 万之间波动。然而，接受筛查的患者中性传播感染的患病率随着时间的推移显著增加，这可能与公众意识的提高和数据记录的改善有关。所有性传播感染中，最高的患病率出现在城市地区和边境附近，私人诊所报告的病例较多，这表明需要在这些地区提高意识，并增加公共卫生诊所的保密性和信任度。
Cochrane Database Syst Rev. 2004
Cochrane Database Syst Rev. 2001
Cochrane Database Syst Rev. 2011-3-16
Public Health Action. 2021-3-21
Bull World Health Organ. 2019-6-6
BMC Med. 2019-2-15
Epidemiol Infect. 2018-12-3
Zotero 插件
